Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review

被引:13
|
作者
Monteiro, Francisca [1 ,2 ,3 ]
Carvalho, Oscar [1 ,3 ]
Sousa, Nuno [2 ,4 ]
Silva, Filipe S. [1 ,3 ]
Sotiropoulos, Ioannis [2 ,4 ,5 ]
机构
[1] Univ Minho, Ctr Microelectromechan Syst CMEMS, Campus Azurem, P-4800058 Guimaraes, Portugal
[2] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal
[3] Univ Minho, Associate Lab, LABBELS, Guimaraes, Portugal
[4] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Campus Gualtar, P-4710057 Braga, Portugal
[5] NCSR Demokritos, Inst Biosci & Applicat, Athens, Greece
关键词
Alzheimer's disease; cognitive decline; light-based therapies; photobiomodulation; visual stimulation; LEVEL LASER THERAPY; TRANSCRANIAL LED THERAPY; MOUSE MODEL; CELL APOPTOSIS; LIGHT; BRAIN; PROPAGATION; DYSFUNCTION; RESPONSES; STRESS;
D O I
10.1002/trc2.12249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionGiven the ineffectiveness of the available drug treatment against Alzheimer disease (AD), light-based therapeutic modalities have been increasingly receiving attention with photobiomodulation (PBM) and, more recently, visual stimulation (VS) being among the most promising approaches. However, the PBM and VS light parameters tested so far, as well as their outcomes, vary a lot with conflicting results being reported. MethodsBased on Scopus, PubMed, and Web of Science databases search, this systematic review summarizes, compares, and discusses 43 cell, animal, and human studies of PBM and VS related to cognitive decline and AD pathology. ResultsPreclinical work suggests that PBM with 640 +/- 30-nm light and VS at 40 Hz attenuates A beta and Tau pathology and improves neuronal and synaptic plasticity with most studies pointing towards enhancement of degradation/clearance mechanisms in the brain of AD animal models. Despite the gap of the translational evidence for both modalities, the few human studies performed so far support the use of PBM at 810-870 nm light pulsing at 40 Hz for improving brain network connectivity and memory in older subjects and AD patients, while 40 Hz VS in humans seems to improve cognition; further clinical investigation is urgently required to clarify the beneficial impact of PBM and VS in AD patients. DiscussionThis review highlights PBM and VS as promising light-based therapeutic approaches against AD brain neuropathology and related cognitive decline, clarifying the most effective light parameters for further preclinical and clinical testing and use. HighlightsLight-based brain stimulation produces neural entrainment and reverts neuronal damageBrain PBM and VS attenuate AD neuropathologyPMB and VS are suggested to improve cognitive performance in AD patients and animal modelsLight stimulation represents a promising therapeutic strategy against neurodegeneration
引用
收藏
页数:24
相关论文
共 50 条
  • [31] Peripheral Inflammatory Biomarkers and Cognitive Decline in Older Adults With and Without Alzheimer's Disease A Systematic Review
    Li, Danni
    Yu, Fang
    JOURNAL OF GERONTOLOGICAL NURSING, 2017, 43 (12): : 53 - +
  • [32] The Efficacy of Vitamin D Supplementation in Patients With Alzheimer's Disease in Preventing Cognitive Decline: A Systematic Review
    Chakkera, Mohana
    Ravi, Niriksha
    Ramaraju, Rajita
    Vats, Aastha
    Nair, Athira R.
    Bandhu, Atithi K.
    Koirala, Divya
    Pallapothu, Manoj R.
    Marinez, Maria G. Quintana
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [33] Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
    Lyduine E. Collij
    Sophie E. Mastenbroek
    Niklas Mattsson-Carlgren
    Olof Strandberg
    Ruben Smith
    Shorena Janelidze
    Sebastian Palmqvist
    Rik Ossenkoppele
    Oskar Hansson
    Nature Communications, 15 (1)
  • [34] Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline
    Peretti, Debora E.
    Boccalini, Cecilia
    Ribaldi, Federica
    Scheffler, Max
    Marizzoni, Moira
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Blennow, Kaj
    Frisoni, Giovanni B.
    Garibotto, Valentina
    BRAIN, 2024, 147 (12) : 4094 - 4104
  • [35] Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
    Teipel, Stefan J.
    Dyrba, Martin
    Kleineidam, Luca
    Brosseron, Frederic
    Levin, Fedor
    Bruno, Davide
    Buerger, Katharina
    Cosma, Nicoleta
    Schneider, Luisa-Sophie
    Duezel, Emrah
    Glanz, Wenzel
    Fliessbach, Klaus
    Janowitz, Daniel
    Kilimann, Ingo
    Laske, Christoph
    Munk, Matthias H.
    Maier, Franziska
    Peters, Oliver
    Pomara, Nunzio
    Perneczky, Robert
    Rauchmann, Boris-Stephan
    Priller, Josef
    Ramirez, Alfredo
    Roy, Nina
    Schneider, Anja
    Spottke, Annika
    Spruth, Eike J.
    Roeske, Sandra
    Wagner, Michael
    Wiltfang, Jens
    Wolfsgruber, Steffen
    Bartels, Claudia
    Jessen, Frank
    Heneka, Michael T.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (01)
  • [36] Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer's Disease Pathology, and Cognitive Decline
    Ouanes, Sami
    Clark, Christopher
    Richiardi, Jonas
    Marechal, Benedicte
    Lewczuk, Piotr
    Kornhuber, Johannes
    Kirschbaum, Clemens
    Popp, Julius
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [37] Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease
    Hussain, Azhar
    Tabrez, Elsa S.
    Mavrych, Volodymyr
    Bolgova, Olena
    Peela, Jagannadha Rao
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2018, 28 (01): : 67 - 72
  • [38] Natural History of Functional Decline in Alzheimer's Disease: A Systematic Review
    Delva, Fleur
    Auriacombe, Sophie
    Letenneur, Luc
    Foubert-Samier, Alexandra
    Bredin, Alain
    Clementy, Anne
    Latxague, Chrystelle
    Puymirat, Emmanuel
    Ballan, Guillaume
    Delabrousse-Mayoux, Jean-Phillipe
    Glenisson, Laurent
    Mazat, Lise
    Spampinato, Umberto
    Rainfray, Muriel
    Tison, Francois
    Dartigues, Jean-Francois
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 40 (01) : 57 - 67
  • [39] Ginseng for Cognitive Function in Alzheimer's Disease: A Systematic Review
    Lee, Myeong Soo
    Yang, Eun Jin
    Kim, Jong-In
    Ernst, Edzard
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 339 - 344
  • [40] Reversal of cognitive decline in Alzheimer's disease
    Bredesen, Dale E.
    Amos, Edwin C.
    Canick, Jonathan
    Ackerley, Mary
    Raji, Cyrus
    Fiala, Milan
    Ahdidan, Jamila
    AGING-US, 2016, 8 (06): : 1250 - 1258